Viral proteins mimic host protein structure and function to redirect cellular processes and subvert innate defenses 1 . Small basic proteins compact and regulate both viral and cellular DNA genomes. Nucleosomes are the repeating units of cellular chromatin and play an important part in innate immune responses 2 . Viralencoded core basic proteins compact viral genomes, but their impact on host chromatin structure and function remains unexplored. Adenoviruses encode a highly basic protein called protein VII that resembles cellular histones 3 . Although protein VII binds viral DNA and is incorporated with viral genomes into virus particles 4,5 , it is unknown whether protein VII affects cellular chromatin. Here we show that protein VII alters cellular chromatin, leading us to hypothesize that this has an impact on antiviral responses during adenovirus infection in human cells. We find that protein VII forms complexes with nucleosomes and limits DNA accessibility. We identified post-translational modifications on protein VII that are responsible for chromatin localization. Furthermore, proteomic analysis demonstrated that protein VII is sufficient to alter the protein composition of host chromatin. We found that protein VII is necessary and sufficient for retention in the chromatin of members of the high-mobility-group protein B family (HMGB1, HMGB2 and HMGB3). HMGB1 is actively released in response to inflammatory stimuli and functions as a danger signal to activate immune responses 6,7 . We showed that protein VII can directly bind HMGB1 in vitro and further demonstrated that protein VII expression in mouse lungs is sufficient to decrease inflammationinduced HMGB1 content and neutrophil recruitment in the bronchoalveolar lavage fluid. Together, our in vitro and in vivo results show that protein VII sequesters HMGB1 and can prevent its release. This study uncovers a viral strategy in which nucleosome binding is exploited to control extracellular immune signalling.
and found it present in both viral replication centres stained for viral DNAbinding protein (DBP; Fig. 1a and Extended Data Fig. 1a ), and in cellular chromatin stained for histone H1 and 4′,6diamidino 2phenylindole (DAPI; Fig. 1b ). These observations suggest that protein VII functions on both viral and host genomes. To determine the impact of protein VII on cellular chromatin, we generated cell lines with inducible expression. In multiple cell types we observed that pro tein VII accumulation altered nuclear DNA into a punctate appearance ( Fig. 1c and Extended Data Fig. 1b , c). We tested whether other basic proteins produce similar effects on chromatin. Viral core protein V and the precursor of protein VII (preVII) localized to nucleoli and did not affect chromatin appearance (Extended Data Fig. 1d ). Human pro tamine PRM1, a basic protein involved in sperm DNA compaction 13 , also localized to nucleoli and did not affect chromatin appearance (Extended Data Fig. 1d ). Taken together, our data demonstrate that protein VII is sufficient to alter cellular chromatin and is distinct from other small basic proteins.
To affect cellular chromatin at the nucleosome level during infection, we reasoned that protein VII must be abundant and associated with histones. Acid extraction of histones 14, 15 from infected cells revealed viral proteins VII and V isolated with cellular histones (Fig. 1d ), as verified by western blot (Extended Data Fig. 2a ) and mass spectrometry (MS). Protein VII abundance was comparable to cellular histone levels ( Fig. 1d ). We further analysed association of protein VII with cellular chromatin by salt fractionation of nuclei 16 . We found protein VII with cellular histones and DNA in highsalt fractions ( Fig. 1e and Extended Data Fig. 2b-d ). Ectopically expressed protein VII is also found in high salt fractions, in contrast to other viral proteins that elute at low salt ( Fig. 1e and Extended Data Fig. 2b ). These data suggest that protein VII is highly abundant and tightly associated with cellular chromatin.
We hypothesized that protein VII interacts with chromatin by form ing complexes with DNA, histones or nucleosomes, and examined protein VII interactions in vitro. Purified recombinant protein VII binds to DNA 5 (Extended Data Fig. 2e,f) . We reconstituted nucle osomes in vitro with recombinant histone proteins on 195 base pairs (bp) of DNA 17 . Protein VII changed nucleosome mobility upon native gel electrophoresis ( Fig. 1f and Extended Data Fig. 2g ). We analysed native gel bands by denaturing SDS-polyacrylamide gel electropho resis (SDS-PAGE), and confirmed that complexes contained core histones with protein VII (Fig. 1f, bottom) . Unlike protamines 13 , pro tein VII forms complexes with nucleosomes but does not appear to replace histones. Next, we examined whether protein VII association LETTER RESEARCH with nucleosomes affects DNA wrapping using microccocal nuclease (MNase) digestion followed by DNA fragment analysis 17 . We found that protein VII pauses nucleosomal DNA digestion at ~165 bp, the point at which DNA strands cross over the nucleosome dyad ( Fig. 1g and Extended Data Fig. 3a ). By contrast, nucleosome digestion alone paused with core particles at ~150 bp, suggesting that protein VII encumbers DNA access. Unlike linker histone binding that is depend ent on DNA length 18 , protein VII protects against MNase digestion on the nucleosome core particle of 147 bp (Extended Data Fig. 3b ). Protein VII alone protects DNA from MNase digestion, as would be expected given its role in the viral core. Together, these data demonstrate that protein VII binds directly to nucleosomes and limits DNA accessibility at the DNA entry/exit site.
Posttranslational modifications (PTMs) on histones are central to regulating chromatin structure 14, 19 . Owing to the histonelike nature of protein VII (ref. 3) , we hypothesized that it is subject to posttranslational modification similar to histones. PreVII was pre viously proposed to be acetylated by Nterminal addition during pro tein synthesis 20 . We noted that protein VII contains conserved lysine residues within an AKKRS motif 21 , similar to the commonly modi fied canonical histone motif ARSK 19 . We therefore purified protein VII from histone extracts over an adenovirus infection time course by reversephase highperformance liquid chromatography (RPHPLC; Fig. 2a and Extended Data Fig. 4 ). Consistent with observations from histone extracts ( Fig. 1d ), protein VII levels were comparable to endog enous histones. We digested purified protein VII and preVII with chy motrypsin to distinguish the two proteins, and analysed peptides by tandem mass spectrometry (MS/MS). We identified several PTMs, with two acetylation sites and three phosphorylation sites the most abundant modifications ( Fig. 2b and Extended Data Figs 5, 6b) . Interestingly, we identified acetylation sites on ectopically expressed protein VII but not on protein VII in virus particles (Extended Data Fig. 6a ). We specu late that this provides a possible mechanism for distinguishing protein VII bound to cellular chromatin from protein destined for packaged virus. To investigate the relevance of the identified PTMs, we mutated modified sites in protein VII. An alaninereplacement mutant for all five PTM sites localized to nucleoli instead of cellular chromatin ( Fig. 2c ). Results with individual point mutations suggest that the K3 residue is important for chromatin localization, and employing glutamine as an acetylation mimic (K3Q) mirrored the pattern of wildtype protein (Fig. 2c ). Effects induced by protein VII are not due to global alteration of histone PTMs since only six PTMs on histones H3 and H4 showed minor but significant changes (Extended Data Table 1 ). These data suggest that protein VII modification has critical roles during virus infection.
To determine whether protein VII manipulation of cellular chroma tin is part of a strategy to counteract host defences, we employed MS to examine changes in the protein composition of nuclear fractions. We compared the total chromatin proteome in the presence and absence of protein VII ( Fig. 3a and Supplementary Table 2 ). We identified 20 proteins that changed significantly across three biological replicates (Extended Data Fig. 7 and Supplementary Table 2 ). The categories of proteins most significantly changed upon protein VII expression were 
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related to immune responses (Extended Data Fig. 7c ). The top four proteins enriched in chromatin fractions by protein VII were SET (also known as TAF1), a protein previously shown to interact with protein VII 22,23 , and HMGB1, HMGB2 and HMGB3 (Fig. 3a) . The HMGB proteins are alarmins with multiple functions as activators of immu nity and inflammation 6, 7 . HMGB1 is a nuclear protein normally only transiently associated with chromatin 24,25 . Cells also release HMGB1 as an extracellular danger signal that promotes immune responses after injury or infection 26 . We confirmed increased chromatin asso ciation of HMGB1 and HMGB2 by analysis of fractionated nuclei, upon protein VII expression and during adenovirus infection (Fig.  3b ). We verified that these changes are not due to altered HMGB1 expression levels (Extended Data Fig. 8a, b ). We demonstrated direct binding of recombinant protein VII to HMGB1 in vitro and confirmed HMGB1 coimmunopreciptation with protein VII (Fig. 3c ). We visually observed reorganization of HMGB1 and HMGB2 distribution upon protein VII expression, and at late stages of infection ( Fig. 3d-f and Extended Data Fig. 8c-e ). We also showed reorganization of HMGB1 distribution by vector transduction to express proteinVII-green fluorescent protein (GFP; Fig. 3g and Extended Data Fig. 8f ). The effect of protein VII on HMGB1 is also conserved across human adenovirus serotypes (Extended Data Fig. 8g ). We further defined the effects of protein VII on HMGB1 mobility by fluorescence recovery after photobleaching (FRAP) and found decreased HMGB1 diffusion ( Fig. 3h ). We next investigated whether protein VII is necessary for chromatin retention of HMGB1 during virus infection. We used a replicationcompetent adenovirus with loxP sites inserted on either side of the protein VII gene, allowing deletion of protein VII during 
infection of cells expressing Cre recombinase (Fig. 3i , j and Extended Data Fig. 9a . b). We fractionated nuclei from infected cells and found that HMGB1 and HMGB2 were no longer retained in chromatin when protein VII was deleted ( Fig. 3k and Extended Data Fig. 9c ). Together, these data indicate that protein VII is necessary and sufficient to promote chromatin association and immobilization of HMGB1.
We hypothesized that protein VII retains HMGB1 in chromatin during natural infection to prevent cellular release and abrogate host immune responses. We therefore visualized endogenous HMGB1 dur ing adenovirus infection in precisioncut lung slices 27 from human donors ( Fig. 4a ). Consistent with cell culture experiments, we demon strate that protein VII is sufficient to relocalize endogenous HMGB1. We then tested whether protein VII prevents HMGB1 release in cell culture and in vivo models. We expressed GFP or proteinVII-GFP in macrophagelike THP1 cells, and confirmed that proteinVII-GFP was sufficient to alter chromatin and HMGB1 localization (Extended Data Fig. 9d ). Cells were treated to stimulate inflammasomes, and HMGB1 content was analysed in supernatants. Protein VII expression resulted in reduced levels of HMGB1 and HMGB2 in supernatants ( Fig. 4b, c ). Subsequently, we employed a murine model of lipopolysac charide (LPS)induced lung injury 28 to investigate the impact of protein VII on HMGB1 release and neutrophil recruitment in vivo ( Fig. 4d ). We confirmed that protein VII was expressed in transduced mouse lungs (Extended Data Fig. 10a -c) and retained mouse HMGB1 (Extended Data Fig. 9e , f). We exposed mice to inhaled LPS to induce HMGB1 release and neutrophil recruitment to alveoli. Bronchoalveolar lavage fluid obtained 24 h after LPS exposure showed that mice transduced to express protein VII had significantly less HMGB1 and fewer neutro phils than mice expressing GFP ( Fig. 4d-f ). Together, these data suggest that protein VII functions in cellular chromatin to retain HMGB1 as a mechanism to blunt immune responses.
In addition to known roles on packaged viral DNA 29,30 , we show that protein VII interacts with cellular chromatin and binds nucleosomes. We suggest that protein VII PTMs contribute to chromatin localization, and that protein VII affects the chromatin association of host proteins. Finally, we show that protein VII in cellular chromatin leads to seques tration of HMGB family members, contributing to abrogated immune responses (Extended Data Fig. 10d ). Our study reveals that chromatin retention of signalling molecules by a viral protein may represent a previously unrecognized immune evasion strategy.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
LETTER RESEARCH METHODS Cells. Primary SAECs, U2OS, HeLa, 293, THP1 and A549 cells were obtained from the American Type Culture Collection (ATCC) and grown according to the provider's instructions. Cell lines were not authenticated or tested for myco plasma. Acceptor cells for generation of inducible cell lines were provided by E. Makeyev and used as previously reported 31 . Protein VII, preVII and V were cloned from genomic DNA isolated from HeLa cells infected with adenovirus type 5 and inserted into the inducible plasmid cassette with a Cterminal HA tag using restriction enzymes BsrGI and AgeI (primer sequences available upon request). Positive clones were selected in DH5α cells, sequenced, and transfected into A549, U2OS or HeLa acceptor cells along with plasmid expressing the Cre recombinase. Recombined clones were selected by puromycin resistance (1 μg ml −1 ) and induced with doxycycline (0.2 μg ml −1 ) to express the desired protein. Protein expression was verified by immunofluorescence and western blot. All figures shown are after 4 days of induction unless otherwise stated. Protein VII and preVII were also verified by HPLC purification and MS analysis. Point mutations were generated by gene synthesis from Genewiz. 293Cre cells were provided by P. Hearing. Viruses and infections. Wildtype Ad5, Ad9, Ad12 and recombinant adenovirus vectors expressing only GFP were propagated in 293 cells as previously described 32 .
Recombinant adenovirus vector with proteinVII-GFP replaced in the E1 region was a gift from D. Curiel 33 . Infections were carried out as described previously 34 using a multiplicity of infection of 10 for primary cells and cell lines for Ad5 infections. Ad9 and Ad12 infections were carried out with a multiplicity of infec tion of 50 and 20, respectively. Ad5floxVII was generated by P. Hearing and also prepared using standard methods in 293 cells. loxP sites were added flanking protein VII in the Ad5 genome resulting in protein VII deletion during infection of 293 cells expressing Cre recombinase. Antibodies. Primary antibodies were purchased from Covance (HA MMS101R), Abcam (H1 ab4269, H3 ab1791, HMGB1 ab18256, HMGB2 ab67282), Millipore (H2A 07146, prosurfactinC AB3786), and Santa Cruz (Ku86 sc5280, tubulin sc69969). The antibodies to DBP, adenoviral late proteins, terminal protein and protein VII were gifts from A. Levine 35 , J. Wilson 32 , R. Hay and L. Gerace, respec tively. Secondary antibodies for immunoblotting were obtained from Jackson ImmunoResearch and secondary antibodies for immunofluorescence were obtained from Life Technologies. Immunofluorescence. Cells were grown on glass coverslips in 24well plates and either infected or induced with doxycycline (0.2 μg ml −1 ). Cells were harvested for immunofluorescence at the indicated time points, washed in PBS, fixed in 4% paraformaldehyde for 15 min and postfixed with 100% icecold methanol for 5 min. Coverslips were then blocked and stained as previously described 36 and mounted using ProLong Gold Antifade Reagent (Life Technologies). Immunofluorescence was visualized using a Zeiss LSM 710 Confocal microscope (Cell and Developmental Microscopy Core at UPenn) and ZEN 2011 software. Images were processed using ImageJ and assembled with Adobe CS6. Immunoblotting. Western blot analysis was carried out using standard methods. Briefly, equal amounts of total protein lysates were separated by SDS-PAGE and transferred to a nitrocellulose membrane (Millipore) for at least 30 min at 30 V. Membranes were stained with ponceau to confirm protein loading and blocked in 5% milk in TBST containing 0.1% azide. Membranes were incubated with pri mary antibodies overnight, washed for 30 min in TBST and incubated with sec ondary antibodies conjugated to horseradish peroxidase (Jackson Laboratories) for 1 h. Membranes were washed again and proteins were visualized with Pierce ECL Western Blotting Substrate (Thermo Scientific) and detected using a Syngene GBox. Mice. All mice were housed in specificpathogenfree (SPF) conditions in an ani mal facility at the Children's Hospital of Philadelphia. All studies in mice were carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee, Children's Hospital of Philadelphia Animal Welfare Assurance Number A344201. C57BL/6J male mice aged 8-10 weeks were used for experiments. Mice were sedated with ketamine and xylazine. Once sedated, mice underwent orotrachial intubation, as previously described 37 , with a 20G angiocatheter from BD. Mice subsequently received 5 × 10 10 genome copies (GC) of recombinant adenovirus expressing proteinVII-GFP or GFP purified by the Penn Vector Core. Four days after infection, mice were exposed to aerosolized LPS, 3 mg ml −1 for 30 min as previously described 38 . One day after LPS exposure, bronchoalveolar lavage (BAL) and lung tissue were harvested as previously detailed 39 and examined for HMGB1 content (ELISA, Chondrex 6010) and neutrophil count (haematoxylin and eosin stain kit EMD 65044/93). Immunostaining was carried out by the CHOP Pathology Core using standard methods. A minimum of four biological replicates were used for each condition studied. Mice were assigned a random number and colour at the start of the experiment and were randomized. Technicians carrying out the experiments were blinded to the identity of the samples. Tissue samples were assigned a random study number such that the technician performing the analysis was blinded. Unblinding for the purpose of data analysis occurred only after all data had been collected. Salt fractionation of nuclei. Salt fractionation of nuclei was adapted from estab lished protocols 16, 40 . Briefly, 2-4 × 10 7 cells were collected and resuspended in 2 ml of icecold buffer I (0.32 M sucrose, 60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 0.1 mM EGTA, 15 mM Tris, pH 7.5, 0.5 mM dithiothreitol (DTT), 0.1 mM PMSF and protease inhibitor cocktail from Roche). To dissolve the plasma membrane, 2 ml icecold buffer I supplemented with 0.1% IGEPAL were added and samples were incubated on ice for 10 min. The 4 ml of nuclei was layered on 8 ml of icecold buffer II (1.2 M sucrose, 60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 0.1 mM EGTA, 15 mM Tris, pH 7.5, 0.5 mM DTT, 0.1 mM PMSF and protease inhibitor cocktail from Roche) and centrifuged for 20 min at 10,000g and 4 °C. The pelleted nuclei were resuspended in 400 μl buffer III (10 mM Tris pH 7.4, 2 mM MgCl 2 , 0.1 mM PMSF) supplemented with 5 mM CaCl 2 and the DNA was digested to mononucle osomes by addition of 1 unit of MNase (SigmaAldrich, N3755). The reaction was incubated at 37 °C for 30 min and then stopped by addition of 25 μl of 0.1 M EGTA. The samples were centrifuged for 10 min, 350g, at 4 °C, and supernatants were set aside for western blot analysis. The pellet was resuspended in 400 μl of buffer IV (70 mM NaCl, 10 mM Tris pH 7.4, 2 mM MgCl 2 , 2 mM EGTA, 0.1% Triton X100, 0.1 mM PMSF) with 80 mM salt and rotated for 30 min at 4 °C. The sample was centrifuged for 10 min at 350g, 4 °C, and the supernatant collected for western blot analysis. This step was repeated for salt concentrations in buffer IV of 150 mM, 300 mM and 600 mM. The final pellet was resuspended in 400 μl H 2 O and all sam ples were analysed together by western blot. An aliquot of each supernatant was set aside for DNA purification using a PCR purification kit (Qiagen) and analysed by agarose gel electrophoresis. Alternatively, 4 × 10 7 cells were resuspended in 400 μl hypotonic buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 1:1,000 PMSF, 0.5 mM DTT) and incubated on ice for 30 min. The cells were transferred to a 1 ml dounce tissue grinder and the cell membranes were gently disrupted with 40 strokes of a tightfitting pestle. The samples were centrifuged for 5 min at 1,500g and 4 °C. The pelleted nuclei were resuspended in 400 μl buffer III and the fractionation was continued as described earlier. Preparation of salt fractions for MS analysis. All chemicals used for prepara tion of MS samples were of at least sequencing grade and purchased from Sigma Aldrich, unless otherwise stated. Only the 600 mM salt fraction was used for LCMS/MS analysis. The 0.1% Triton X100 detergent was removed from sam ples bofore MS analysis by precipitation using chloroform (CHCl 3 )methanol (MeOH) precipitation 41 . The protein pellet from CHCl 3 MeOH precipitation was resuspended in 6 M urea and 2 M thiourea in 50 mM ammonium bicarbonate. Samples were reduced with 10 mM DTT for 1 h at room temperature and then carbamidomethylated with 20 mM iodoacetamide for 30 min at room temperature in the dark. Afterwards, alkylated proteins were digested first with endopeptidase LysC (Wako, MS grade) for 3 h, after which the solution was diluted 10 times with 20 mM ammonium bicarbonate. Subsequently, samples were digested with trypsin (Promega) at an enzymetosubstrate ratio of approximately 1:50 for 12 h at room temperature. The samples were acidified with 5% formic acid (FA) to a pH ≤ 3 and desalted using Poros Oligo R3 RP columns (PerSeptive Biosystems) packed in a P200 stage tip with C 18 3 M plug (3M Bioanalytical Technologies). Purified peptide samples were dried by lyophilization and stored at −20 °C until further analysis. This procedure was carried out for three biological replicas. Nano-LC-MS/MS and analysis of salt fractions. Samples were loaded onto a 16 cm C 18 -AQ column (inner diameter 75 μm, 3 μm beads, Dr, Maisch GmbH, Germany) using an Easy nanoflow HPLC system (Thermo Fisher Scientific). The nanoLC was coupled to an Orbitrap Fusion Tribrid Mass Spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source (Thermo Fisher Scientific). Peptides were loaded in buffer A (0.1% formic acid) and eluted with a 120 min linear gradient from 2-30% buffer B (95% acetonitrile, 0.1% formic acid). After the gradient, the column was washed with 90% buffer B. Mass spectra were acquired using a datadependent acquisition method with the TopSpeed set with 3s cycle. Spectra were acquired in the Orbitrap analyser with mass range of 350-1,200 m/z and 120,000 resolution (200 m/z), with a maximum injection time of 50 ms and an AGC target of 5 × 10 5 . Signals with 2-5 charges were selected for HCD fragmentation using a normalized collision energy of 27, a maximum injec tion time of 120 ms and an AGC target of 10,000. Fragments were analysed in the ion trap. Raw MS files were analysed by MaxQuant (v.1.5.2.8) 42 (http://www. maxquant.org). MS/MS spectra were searched against the UniProthuman data base (version June 2014, 59,345 entries). All used search parameters were default, with the exception of including the match between runs (1 min window) and the intensitybased absolute quantification (iBAQ) labelfree quantification 43 . The search included variable modifications of methionine oxidation and Nterminal acetylation, and fixed modification of carbamidomethyl cysteine. Each iBAQ value was log 2 transformed and subsequently normalized by the aver age protein abundance within each run. Biological process association analysis and process network enrichment were performed using the GeneGo MetaCore pathways analysis package with FDR < 5%; each Gene Ontology term was ranked using Pvalue enrichment. Purification of recombinant protein-VII-His. Protein VII was cloned from genomic DNA isolated from adenovirusinfected HeLa cells into a pET21a back bone to generate a Cterminal hexahistidine tag. Positive clones were selected in DH5α cells, sequenced, and transformed into BL21 (DE3) cells (NEB C2527I). The purification of insoluble proteinVII-His was adapted from existing protocols to purify histone proteins from Escherichia coli 44, 45 . Briefly, BL21 cells were inocu lated from overnight cultures and grown to an optical density of 0.5-0.6 OD 260 nm , induced with 0.1 mM isopropylβdthiogalactoside (IPTG; Sigma) and harvested after 4 h at 37 °C. Cell pellets were resuspended in a mild buffer (50 mM TrisHCl pH 8.0, 500 mM NaCl, 1 mM PMSF, 5% glycerol, 2.5 μg ml −1 aprotinin, leupeptin and pepstatin) and disrupted by sonication using a Branson 250 sonifier. The lysate was then centrifuged at 27,000g for 20 min at 4 °C. The supernatants were discarded and pellets were resuspended in a denaturing buffer (50 mM TrisHCl, pH 8.0, 500 mM NaCl, 5% glycerol, 8 M urea). The suspension was centrifuged again to eliminate insoluble cell debris and the Histagged protein was isolated using a cobalt resin (ThermoScientific 89964) according to the manufacturer's instructions for denaturing conditions. The purified protein was then dialysed against water and lyophilized. Purified protein was verified by western blot and MS. In vitro binding assays. HMGB1-GST (Abnova) or GST (Sigma) were combined with recombinant proteinVII-His at equimolar ratios and incubated at 4 °C for 1 h. Complexes were then mixed with a cobalt resin (ThermoScientific 89964) to bind proteinVII-His and any associated protein and washed three times in the binding buffer (50 mM Tris pH 8, 300 mM NaCl, 0.1% IGEPAL). The beads were then boiled in sample buffer, separated on a 4-12% NuPage gel and visualized by Coomassie staining. Nucleosome in vitro binding and MNase digestion assays. Gel shift and MNase digestion assays were carried out as previously described 17, 46, 47 . Briefly, nucle osomes were reconstituted by incubating purified recombinant histones with '601' DNA of either 195 or 147 bp over a series of dialysis. Recombinant proteinVII-His was then combined with nucleosomes at various molar ratios, incubated at room temperature for 15 min, and analysed by native gel electrophoresis. Complexes were also digested with MNase (Affymetrix) by addition of 1 unit per μg of DNA for 147 bp nucleosome experiments and 0.1 unit per μg of DNA for 195 bp nucle osome experiments, incubated at 22 °C for varying amounts of time followed by the addition of EGTA and guanidine thiocyanate to stop the reaction. The DNA fragments were then purified using a MinElute PCR purification kit (Qiagen) and analysed on an Agilent 2100 Bioanalyzer as previously described 17 . Release assay of HMGB1 in THP-1 cells. THP1 cells were seeded at a density of 2 × 10 5 cells per well in a 24well plate, and stimulated into macrophagelike cells by addition of 10 ng ml −1 PMA for 48 h. Cells were washed in PBS and transduced with recombinant adenovirus vectors expressing only GFP or proteinVII-GFP such that >90% of cells were GFP positive. At 48 h after transduction, cells were washed and 200 μl of serumfree RPMI was added. To stimulate the inflammasome, LPS (SigmaAldrich L2880) with a final concentration of 0.5 μg ml −1 was added to wells and incubated for 2 h, then nigericin (SigmaAldrich N7143) was added with a final concentration of 10 μM for 1 h. Supernatants were collected and proteins precipitated overnight at 4 °C with a final concentration of 20% trichloroacetic acid (Sigma), washed with acetone, dried, and resuspended in 1 × LDS sample buffer with reducing agent (Invitrogen). For ELISA analysis, supernatants were harvested directly and HMGB1 content was detected by the manufacturer's instructions (Chondrex 6010). Cells were also harvested by the addition of 1 × LDS sample buffer with reducing agent (Invitrogen) and boiled. Supernatants and lysates were analysed together by western blot. Acid extraction and RP-HPLC. Histones were prepared for MS analysis as detailed previously 48 . Nuclei were isolated and histones from infected cells were extracted by acid as previously described 14 . The preVII and protein VII vari ants were fractionated using an offline RPHPLC. Briefly, ~100 μg proteins were resuspended in buffer A (0.1% trifluoroacetic acid (TFA) in HPLCgrade water) and loaded onto a C 18 5 μm column (4.6 mm internal diameter × 250 mm, Vydac) using a Beckman Coulter (System GoldA) HPLC (buffer A: 0.1% TFA; buffer B: 95% acetonitrile, 0.08% TFA). The proteins were separated using a gradient from 30 to 45% buffer B in 100 min at a flow rate of 0.2 ml min −1 . The fractions containing the proteins of interest were collected using an automatic fraction collector and individual peaks were combined based on their ultraviolet signal. The fractions were subsequently dried by vacuum centrifugation and prepared for MS (see later). Protein VII was purified from three biological replicates and analysed as follows for MS. MS analysis of protein VII PTMs. Sample preparation/protein VII. RPHPLC purified samples of protein VII variants were reduced in 10 mM DTT in 50 mM ammonium bicarbonate for 1 h at 56 °C. After cooling to room temperature, sam ples were alkylated in 20 mM iodoacetamide in 50 mM ammonium bicarbonate for 30 min in the dark. Samples were digested with chymotrypsin or ArgC, at an enzymetosubstrate ratio of approximately 1:20 for 8 h at 37 °C. The samples were acidified to a final concentration of 5% formic acid to a pH ≤ 3 and desalted using P200 stage tip columns packed with C 18 3 M plug (3M Bioanalytical Technologies). Purified peptide samples were dried by lyophilization and stored at −20 °C until further analysis. Nano-LC-MS/MS analysis of histone PTMs. The nanoLCMS/MS analysis was performed as previously described 48 . Nano-LC-MS/MS analysis of protein VII peptides. The nanoLCMS/MS analysis was performed in triplicate for each sample. Samples were loaded onto a 16 cm C 18 -AQ column (inner diameter 75 μm, 3 μm beads, Dr, Maisch GmbH) using an Easy nanoflow HPLC system (Thermo Fisher Scientific). The nanoLC was coupled to an Orbitrap Velos Pro Mass Spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source (Thermo Fisher Scientific). Peptides were loaded in buffer A (0.1% formic acid) and eluted with a 45 min linear gradient from 2 to 30% buffer B (95% acetonitrile, 0.1% formic acid). After the gradient, the column was washed with 90% buffer B. Mass spectra were acquired using a datadependent acquisition method with the top 15 most intense ions. Spectra were acquired in the Orbitrap analyser with mass range of 350-1,600 m/z and 60,000 resolution (400 m/z), with a maximum injection time of 10 ms and an AGC target of 10 × 10 6 . Signals above 1,000 count charges were selected for HCD fragmentation using normalized collision energy of 36, a maximum injection time of 100 ms and an AGC target of 50,000. Fragments were analysed in the orbitrap. Data processing of protein VII spectra. Raw mass spectrometer files were ana lysed using Proteome Discoverer (v.1.4, Thermo Scientific). MS/MS spectra were converted to .mgf files and searched against the UniProt adenovirus C serotype 5 database using Mascot (v.2.5, Matrix Science). Database searching was performed with the following parameters: precursor mass tolerance 10 p.p.m.; MS/MS mass tolerance 0.05 Da; enzyme chymotrypsin (Promega) or ArgC (Roche), with two missed cleavages allowed; fixed modification was cysteine carbamidomethylation; variable modifications were methionine oxidation, serine/threonine/tyrosine phos phorylation, lysine acetylation and methylation, asparagine and glutamine deami dation. Specifically, phosphorylation, acetylation, and methylation were searched separately, not as coexisting modifications. Peptides were filtered for <1% FDR, Mascot ion score >20 and peptide rank 1. Co-immunoprecipitation of protein-VII-HA. A549 cells were induced to express protein VII with doxycycline for 4 days as described earlier. Approximately 4 × 10 7 cells were harvested and pelleted for each immuno precipitation reaction. Cell pellets were resuspended in 500 μl of IC wash buffer with protease inhibitors (20 mM HEPES pH 7.9, 110 mM KOAc, 2 mM MgCl 2 , 150 mM NaCl, 0.1% Tween20, 0.1% Triton X100) and incubated on ice for 10 min with intermittent vortexing to disrupt cells. Samples were then incubated on ice for 1 h with 5 μl of benzonase (Millipore) added to each sample to digest DNA to ~150 bp, which was confirmed by DNA isolation and agarose gel analysis. Samples were then sonicated in a Diagenode Bioruptre for 30 s on and 30 s off for five rounds at 4 °C and centrifuged at 14,000g for 15 min at 4 °C. Supernatants were then incubated rotating for 1 h at 4 °C with 30 μl of HAconjugated magnetic beads (Thermo Scientific) and washed three times for 5 min in IC buffer. Isolated proteins were eluted with 100 μl of 2 mg ml −1 HA peptide (Thermo Scientific) for 20 min rotating at 37 °C and separated on an SDS-PAGE gel. For protein separation by SDS-PAGE the NuPAGE 1DE System was used (NuPAGE Novex 4-12% BisTris 1.0 mm gels, Invitrogen). Uninduced cells were used as a negative control. The immunopreciptation was carried out in biological triplicate and pulldown of proteinVII-HA and HMGB1 was confirmed by western blotting standard techniques as described earlier. Quantitative PCR. Genomic DNA was isolated using the PureLink Genomic DNA kit (Thermo Scientific). Quantitative PCR was performed using primers specific for viral DBP (5′GCCATTGCGCCCAAGAAGAA and 5′CTGTCCACGATTACCTCTGGTGAT), protein VII (5′GCGGGT ATTGTCACTGTGC and 5′CACCCAATACACGTTGCCC), and cellular tubulin (5′CCAGATGCCAAGTGACAAGAC and 5′GAGTGAGTGACAA GAGAAGCC). Values for DBP and protein VII were normalized internally to tubulin and to the 4 h time point to control for any variation in virus input. RNA was isolated using the RNeasy Mini Kit (Qiagen) and reverse tran scribed using the High Capacity RNA to cDNA Kit (Applied Biosystems). Quantitative PCR was performed using primers specific for HMGB1 LETTER RESEARCH (5′TAACTAAACATGGGCAAAGGAG and 5′TAGCAGACATGGTCTTCCAC) and βactin (5′GCACCACACCTTCTACAATGAG and 5′GGTCTCAA ACATGATCTGGGTC). Quantitative PCR was performed using the standard protocol for Sybr Green (Thermo Scientific) and analysed using the ViiA 7 Real Time PCR System (Thermo Scientific). Precision-cut lung slice immunofluorescence. Precisioncut lung slices were obtained and prepared as previously described 27, 49 . Deidentified human lung tissue from donors was obtained from the National Disease Research Interchange. Analysis of human samples was approved by the University of Pennsylvania Internal Review Board. Samples were infected with 10 8 plaqueforming units (p.f.u.) of Ad5 per slice or 10 9 GC of rAd proteinVII-GFP for 24 h. Samples were fixed in 4% PFA at room temperature for 15 min and washed three times in PBS. Samples were permeabilized with 0.5% Triton X100 and washed twice more in PBS. Samples were then incubated with 3% BSA and 0.03% Triton X100 in PBS for 1 h to block. Primary antibodies (DBP or HMGB1) were incubated in the same buffer for 1 h and then samples were washed three times in PBS with 3% BSA, incubated with secondary antibodies and DAPI for 1 h, and washed three more times. Whole slices were mounted on slides with mounting solution and imaged by confocal microscopy. FRAP. Fulllength HMGB1 was cloned from pcDNA3.1 FlaghHMGB1 (Addgene 31609) into pEGFPN1 containing a L221K mutation to prevent dimerization of GFP molecules 50 . A549 cells were induced to express protein VII for 4 days with doxycycline in glassbottom dishes. Cells were then transfected with the con struct that constitutively expresses HMGB1 with a monomeric GFP Cterminal tag. FRAP was carried out using standard methods on a Zeiss LSM 710 confocal microscope. Diffusion coefficients were calculated using the 'simFRAP' algo rithm (http://imagej.nih.gov/ij/plugins/simfrap/index.html), a simulation based approach to FRAP analysis 51 . Statistical analyses. Statistical details are reported in each figure legend. Statistical analyses were performed on at least three different biological replicates, unless oth erwise stated in the figure legend. The sample size was chosen to provide enough statistical power to apply parametric tests (one or twotailed homoscedastic ttest).
The ttest was considered a valuable statistical test since binary comparisons were performed and the number of replicates was limited. Furthermore, we applied the homoscedastic ttest assuming that the variance between the two data sets would remain homogeneous due to the use of the same cell lines in culture with and without protein VII expression. No samples were excluded as outliers (this applies to all proteomics analyses described in this manuscript). Proteins with a P value smaller than 0.05 were considered to be significantly altered between the two tested conditions for twotailed and onetailed ttest. Data distribution was assumed to be normal but this was not formally tested. The nanoLCMS/MS analysis was performed in triplicate for each sample to determine technical variation. with MNase for the indicated times, the reaction was stopped, DNA was extracted and analysed. As in Fig. 1g , nucleosomes are shown in black and proteinVII-nucleosome complexes in orange. The presence of protein VII pauses digestion at 165 bp, suggesting that protein VII is blocking access to the DNA. b, 147 bp nucleosomes or proteinVII-nucleosome complexes were incubated with MNase for the indicated times, the reaction was stopped, DNA was extracted and analysed. Graphs show nucleosomes in grey and proteinVII-nucleosome complexes in orange. The presence of protein VII completely blocks digestion even after nucleosomes alone have been digested well beyond the core particle. In contrast to what would be expected for linker histones, protein VII protects the core nucleosome particle from digestion. These data indicate that protein VII may be masking the substrate for MNase through complex formation. This represents a unique mechanism of nucleosome binding and suggests a model for blocking DNA access in cellular chromatin during infection. Fig. 2a . The bands in fraction 38-41 min correspond to histone H1. Protein VII and V, as indicated, were verified by MS analysis (data not shown). The slight upward shift of the protein VII bands in the later peak corresponds to the higher abundance of protein preVII, as seen by HPLC in Fig. 2a. b in proteinVII-HAinduced condition). c, d, Classification of proteins significantly enriched in minimum two out of three biological replicates (proteinVII-HAinduced versus uninduced) according to process network enrichment and Gene Ontology biological process (GeneGo MetaCore pathways analysis package; false discovery rate (FDR) < 5%); each Gene Ontology term was ranked using Pvalue enrichment. . c, Salt fractionation of 293Cre cells infected with wildtype Ad5, indicating that the Cre recombinase does not interfere with the ability of protein VII to retain HMGB1 in the high salt chromatin fraction. Protein VII is also necessary for the chromatin retention of HMGB2. d, THP1 cells transduced to express proteinVII-GFP results in chromatin distortion and HMGB1 retention in chromatin. Immunofluorescence of transduced PMAtreated THP1 cells showing proteinVII-GFP (green), HMGB1 (red) and DNA (grey, blue in merge). e, Transduction to express proteinVII-GFP is sufficient to relocalize mouse HMGB1 in mouse embryonic fibroblast (MEF) cells. f, Salt fractionation of mouse embryonic fibroblast cells transduced to express proteinVII-GFP. Human Ad5 protein VII is sufficient to retain mouse HMGB1 in the highsalt fraction in MEF cells. The control vector expressing GFP alone does not have this effect.

